Patient-Derived Organoid Serves as a Platform for Personalized Chemotherapy in Advanced Colorectal Cancer Patients.

Saved in:
Bibliographic Details
Title: Patient-Derived Organoid Serves as a Platform for Personalized Chemotherapy in Advanced Colorectal Cancer Patients.
Authors: Geevimaan K; Institute of Biomedical Sciences, Academia Sinica, Taipei, Taiwan.; Genomic Research Center, Academia Sinica, Taipei, Taiwan., Guo JY; Institute of Biomedical Sciences, Academia Sinica, Taipei, Taiwan., Shen CN; Genomic Research Center, Academia Sinica, Taipei, Taiwan., Jiang JK; Division of Colon and Rectal Surgery, Department of Surgery, Taipei Veterans General Hospital, Taipei, Taiwan.; Faculty of Medicine, School of Medicine, National Yang Ming Chiao Tung University, Hsinchu, Taiwan., Fann CSJ; Institute of Biomedical Sciences, Academia Sinica, Taipei, Taiwan., Hwang MJ; Institute of Biomedical Sciences, Academia Sinica, Taipei, Taiwan., Shui JW; Institute of Biomedical Sciences, Academia Sinica, Taipei, Taiwan., Lin HT; Institute of Biomedical Sciences, Academia Sinica, Taipei, Taiwan., Wang MJ; Institute of Biomedical Sciences, Academia Sinica, Taipei, Taiwan., Shih HC; Institute of Biomedical Sciences, Academia Sinica, Taipei, Taiwan., Li AF; Department of Pathology, Taipei Veterans General Hospital, Taipei, Taiwan., Chang SC; Division of Colon and Rectal Surgery, Department of Surgery, Taipei Veterans General Hospital, Taipei, Taiwan.; Faculty of Medicine, School of Medicine, National Yang Ming Chiao Tung University, Hsinchu, Taiwan., Yang SH; Division of Colon and Rectal Surgery, Department of Surgery, Taipei Veterans General Hospital, Taipei, Taiwan.; Faculty of Medicine, School of Medicine, National Yang Ming Chiao Tung University, Hsinchu, Taiwan.; Department of Surgery, National Yang Ming Chiao Tung University Hospital, Yilan, Taiwan., Chen JY; Institute of Biomedical Sciences, Academia Sinica, Taipei, Taiwan.
Source: Frontiers in oncology [Front Oncol] 2022 Jun 01; Vol. 12, pp. 883437. Date of Electronic Publication: 2022 Jun 01 (Print Publication: 2022).
Publication Type: Journal Article
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:2234-943X
DOI:10.3389/fonc.2022.883437